Altre lingue Nautilus Biotechnology, Inc.

Azioni

NAUT

US63909J1088

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
2,4 ^USD	-3,61%		-1,23%	-19,73%

28/02	Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024
28/02	Nautilus Biotechnology, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024	11/04
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024	11/04
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results	28/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference	22/02
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference	22/02
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	07/02
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award	30/11
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award	30/11
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development	01/11
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results	31/10/23
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/10/23
Nautilus Biotechnology : Reports Third Quarter 2023 Financial Results - Form 8-K	31/10/23
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023	11/10/23
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023	11/10/23
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences	06/09/23
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences	06/09/23
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences	07/08/23
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences	04/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Nautilus Biotechnology, Inc.

Azioni

NAUT

US63909J1088

Altre lingue

Filtri